Thyroid Cancer is the cancer type originating in Thyroid gland. Though specific causes are not determined, the cancer occurs when thyroid cells undergo mutations, making cells to increase rapidly in count and size, forming tumors.
Types- Thyroid Cancer is categorized into three main types –
- Differentiated Thyroid Cancer Follicular Papillary Hurthle - Follicular Thyroid Cancer Sporadic Familial - Anaplastic Thyroid Cancer
Stages- - Stage I - Tumor less than 2 cm - Stage II - Tumor between 2 cm and 4 cm - Stage III - Tumor more than 4 cm, or grown slightly beyond thyroid - Stage IVa- Tumor expands into nearby neck tissues/ some lymph nodes/ upper chest - Stage IVb- Tumor expands to spine/ blood vessels - Stage IVC: Tumor might be spread to distant sites of body
Companies conducting Follicular Thyroid Cancer trials include- - Immunomedics, Inc. - Exelixis
Follicular Thyroid Cancer clinical trials report from VPA Research provides comprehensive analysis and trends in global Follicular Thyroid Cancer disease clinical trials. The research work analyzes the evolution of Follicular Thyroid Cancer clinical trial trends across countries and regions.
The report focuses on drugs and therapies being evaluated for Follicular Thyroid Cancer treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner offering quick access to Follicular Thyroid Cancer clinical trials.
Major drugs under development in Follicular Thyroid Cancer are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.
Scope of the Report- - Number of Follicular Thyroid Cancer clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas - Trial information by Phase and Subjects recruited - Trial information by status, type, sponsor type - Drugs used for treatment of Follicular Thyroid Cancer - Both observational and interventional trials analyzed - Success rates of trials are analyzed - Trends in enrollment over the past ten years identified - Leading sponsors of Follicular Thyroid Cancer clinical trials worldwide are listed
Reasons to Buy- - Track competition and design competitive advantages - Identify right partners to associate with for further research - Evaluate potential opportunities available in further clinical trials of the disease - Formulate business development strategies through success rates of clinical trials - Identify quick markets for recruiting subjects based on trials count by each market
Our reports have been used by over 10K customers, including:
“XmAb14045 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. A detailed picture of the XmAb14045 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom),...
Fallopian Tube Cancer Market Report Overview Fallopian Tube Cancer market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Fallopian Tube Cancer market types and applications. It is a focused study on Fallopian Tube Cancer market space including...
172 pages •
By Global Industry Analysts
• Mar 2021
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 7
- Influencer Pool: 836
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
The alpha emitter market is expected to witness a healthy CAGR of 36.7% during the forecast period (2020 - 2025). Certain factors that are driving the market growth include increased awareness about the potential benefits of targeted alpha therapy and the growing number of patients with cardiac and cancer ailments. Targeted anticancer...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers, Elsevier B.V., Macmillan and National Decision Support Company. The global cancer clinical decision tools market is expected to decline from $0.38 billion in 2019 to $0.35...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products...
Colorectal Cancer Screening Coverage
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.